BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31673940)

  • 1. ASO Author Reflections: Contralateral Prophylactic Mastectomy-Moving Beyond Sociodemographic Factors.
    Oseni TO; Zhang B
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):834-835. PubMed ID: 31673940
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Neoadjuvant Chemotherapy for Breast Cancer May Not Alter Increasing Trends for CPM Utilization.
    Christian N; Gemignani ML
    Ann Surg Oncol; 2020 Mar; 27(3):750-751. PubMed ID: 31728793
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: What Drives Contralateral Prophylactic Mastectomy?
    Schellenberg AE; Scheer AS
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):821-822. PubMed ID: 31667725
    [No Abstract]   [Full Text] [Related]  

  • 4. ASO Author Reflections: Contralateral Prophylactic Mastectomy in Breast Cancer Patients with CHEK2 Gene Mutations.
    Nizic-Kos T; Besic N
    Ann Surg Oncol; 2021 May; 28(5):2571-2572. PubMed ID: 33073339
    [No Abstract]   [Full Text] [Related]  

  • 5. What is new in the surgical management and prevention of breast cancer?
    Spillane AJ
    Med J Aust; 2016 May; 204(8):311-4. PubMed ID: 27125805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The financial impact and drivers of hospital charges in contralateral prophylactic mastectomy and reconstruction: a Nationwide Inpatient Sample hospital analysis.
    Bucknor A; Chattha A; Ultee K; Wu W; Kamali P; Bletsis P; Chen A; Lee BT; Cronin C; Lin SJ
    Breast Cancer Res Treat; 2017 Sep; 165(2):301-310. PubMed ID: 28634720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State Variation in the Receipt of a Contralateral Prophylactic Mastectomy Among Women Who Received a Diagnosis of Invasive Unilateral Early-Stage Breast Cancer in the United States, 2004-2012.
    Nash R; Goodman M; Lin CC; Freedman RA; Dominici LS; Ward K; Jemal A
    JAMA Surg; 2017 Jul; 152(7):648-657. PubMed ID: 28355431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding Eligibility Criteria for Nipple-Sparing Mastectomy.
    Orcutt ST; O'Donoghue C; Smith P; Laronga C
    South Med J; 2017 Oct; 110(10):654-659. PubMed ID: 28973707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contralateral prophylactic mastectomy.
    ; Simões RS; Bernardo WM; Silvinato A; Frank TA; Buzzini R
    Rev Assoc Med Bras (1992); 2018 Jan; 64(1):3-8. PubMed ID: 29561933
    [No Abstract]   [Full Text] [Related]  

  • 10. Contralateral prophylactic mastectomy: Warnings for a difficult decision to make with caution!
    Franceschini G; Di Leone A; Masetti R
    Am J Surg; 2019 Nov; 218(5):1031-1032. PubMed ID: 30691675
    [No Abstract]   [Full Text] [Related]  

  • 11. Contralateral prophylactic mastectomy.
    Benson JR; Winters ZE
    Br J Surg; 2016 Sep; 103(10):1249-50. PubMed ID: 27465285
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of contralateral prophylactic mastectomy on breast-related charges: A 5-year analysis.
    Smith JR; Jaffe J; Pruitt J; Yao K; Sisco M; Kuchta K; Wang CE; Howard MA
    J Surg Oncol; 2018 Jul; 118(1):212-220. PubMed ID: 30098307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American trends in oncoplastic breast surgery for 2006-2015: A retrospective analysis of NSQIP database.
    Panchal H; Shukla D; Razdan SN; El-Tamer M; Matros E; Henderson PW
    J Plast Reconstr Aesthet Surg; 2021 Mar; 74(3):644-710. PubMed ID: 32888868
    [No Abstract]   [Full Text] [Related]  

  • 14. Discussion: Complications of Contralateral Prophylactic Mastectomy: Do They Delay Adjuvant Therapy?
    Chen AD; Lin SJ
    Plast Reconstr Surg; 2020 Nov; 146(5):954-955. PubMed ID: 33136937
    [No Abstract]   [Full Text] [Related]  

  • 15. National trends in contralateral prophylactic mastectomy in women with locally advanced breast cancer.
    Panchal H; Pilewskie ML; Sheckter CC; Albornoz CR; Razdan SN; Disa JJ; Cordeiro PG; Mehrara BJ; Matros E
    J Surg Oncol; 2019 Jan; 119(1):79-87. PubMed ID: 30480805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mastectomy patterns, but not rates, are changing in the treatment of early breast cancer. Experience of a single European institution on 2315 consecutive patients.
    Fancellu A; Sanna V; Cottu P; Feo CF; Scanu AM; Farina G; Bulla A; Spanu A; Paliogiannis P; Porcu A
    Breast; 2018 Jun; 39():1-7. PubMed ID: 29454174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contralateral Prophylactic Mastectomy: Aligning Patient Preferences and Provider Recommendations.
    Fayanju OM; Hwang ES
    JAMA Surg; 2017 Mar; 152(3):282-283. PubMed ID: 28002558
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic Testing and De-escalation of Contralateral Prophylactic Mastectomy.
    Tuttle TM; Burke EE; Hui JYC
    Ann Surg Oncol; 2021 Sep; 28(9):4764-4766. PubMed ID: 33796999
    [No Abstract]   [Full Text] [Related]  

  • 19. Trends of contralateral prophylactic mastectomy at the time of ipsilateral breast tumor recurrence.
    Am J Surg; 2022 Mar; 223(3):538. PubMed ID: 35177234
    [No Abstract]   [Full Text] [Related]  

  • 20. Nipple-sparing bilateral prophylactic mastectomy and immediate reconstruction with TiLoop
    Casella D; Di Taranto G; Marcasciano M; Sordi S; Kothari A; Kovacs T; Lo Torto F; Cigna E; Ribuffo D; Calabrese C
    Breast; 2018 Jun; 39():8-13. PubMed ID: 29455110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.